BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//IBSAL - ECPv6.18.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:IBSAL
X-ORIGINAL-URL:https://ibsal.es/en/
X-WR-CALDESC:Events for IBSAL
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260921
DTEND;VALUE=DATE:20261212
DTSTAMP:20261028T094445Z
CREATED:20261028T091518Z
LAST-MODIFIED:20261028T094445Z
UID:29255-1789948800-1797033599@ibsal.es
SUMMARY:Integrated Services for Infectious Disease Outbreak Research\, ISIDORe—Andes Virus and ANDV-Related Hantavirus Research
DESCRIPTION:Features\nThe call for proposals titled “Andes Virus & ANDV-relevant Hantavirus Research” is part of ISIDORe II\, an initiative funded by the European Union’s Horizon Europe program to facilitate access to specialized research infrastructure and services for infectious diseases. \nThe main feature is that it does not provide a financial grant to the researcher or their institution. Instead\, it funds access to specialized scientific services provided by the participating infrastructures\, at no cost to the selected users.  \nProposals must address the Andes virus (ANDV) or research on hantaviruses that is clearly related to it. Research on other hantaviruses without justifying that relationship falls outside the scope of this call for proposals.  \nThree priority areas are established: \n\nEvaluation of treatments and non-vaccine-based prophylaxis. Evaluation and characterization of antiviral candidates\, antibodies\, and other therapeutic or preventive strategies that already have a scientific basis. \nDiagnostics\, assays\, and reference materials. Development or adaptation of assays\, evaluation of sensitivity and specificity\, analytical validation\, reagents\, controls\, and reference materials. \nModels and experimental systems. Use and characterization of models to study pathogenesis\, viral tropism\, host response\, or the evaluation of medical countermeasures. \n\n  \nServices available: \n\n\n\n\nAnalysis: RT-PCR design\, NGS sequencing\, and whole-genome sequencing of ANDV. \n\n\n\n\n\n\nDrug discovery: screening of antiviral compounds\, validation of candidates\, and characterization of monoclonal antibodies. \n\n\n\n\n\n\nCell-based and ex vivo models: human organoids\, lung\, placenta\, and endothelial models\, and antiviral assays. \n\n\n\n\n\n\nIn vivo models: preclinical efficacy studies and animal models\, subject to applicable scientific and ethical requirements. \n\n\n\n\n\n\nImmunomonitoring and structural biology: cellular immunity assays\, protein production and characterization\, and advanced microscopy techniques. \n\n\n\n\n\n\nRegulatory and clinical support: guidance on preparing research studies and addressing ethical or regulatory issues. \n\n\n\n\nThe availability of a service in the general catalog does not guarantee that any use of that service is eligible: it must comply with the priorities and exclusions of this specific call for proposals. \n  \n  \nRequirements\nThe call for proposals is open to researchers from universities\, public research institutions\, public health organizations\, companies\, small and medium-sized enterprises\, and other organizations that conduct research. \nThe main requirements and conditions are: \n\n\n\n\nScientific scope: The proposal must address ANDV or an issue related to another hantavirus whose relevance to ANDV is clearly justified. \n\n\n\n\n\n\nAccess to services: You must request one or more services included in the ISIDORe II catalog. \n\n\n\n\n\n\nTransnational dimension: Horizon Europe’s transnational access (TNA) rules apply. The principal investigator and the majority of users must meet the geographic access conditions with respect to the hosting facility. The location of the service is determined during the process.   \n\n\n\n\n\n\nPriority: Preference will be given to applicants who did not receive funding in the first ISIDORe project. \n\n\n\n\n\n\nEthics and security: Applicable requirements regarding ethics\, biosafety\, bioprotection\, data protection\, and the use of services must be met. \n\n\n\n\n\n\nDissemination: The results must be disseminated\, and ISIDORe’s contribution must be appropriately acknowledged. \n\n\n\n\nAt least 80% of access must benefit users from EU Member States or countries associated with Horizon Europe; up to 20% may be allocated to international users who meet the relevant conditions. \nThe call for proposals guidelines state that the following are not included: \n\n\n\n\nRoutine diagnosis and epidemiological surveillance. \n\n\n\n\n\n\nClinical trials. \n\n\n\n\n\n\nManufacturing and scaling of production processes. \n\n\n\n\n\n\nWide-ranging screening campaigns without a specific hypothesis or need. \n\n\n\n\n\n\nDevelopment of entirely new services that are not available in the current offering. \n\n\n\n\nWe are looking for a specific scientific need that can be addressed through specialized services available at the participating research infrastructures. \nHow to apply\nThe application consists of two phases: a preliminary application and a full application. It is important to review the full text of the call for proposals to verify scientific relevance and eligibility criteria. Applications are submitted through the application management system (Access Management System\, AMS).   \nThis link takes you to the services catalog\, where you can view available infrastructure and services.
URL:https://ibsal.es/en/evento/integrated-services-for-infectious-disease-outbreak-research-isidore-andes-virus-and-andv-related-hantavirus-research/
CATEGORIES:Calls for research
END:VEVENT
END:VCALENDAR